Keating Financial Advisory Services’s Annovis Bio ANVS Stock Holding History

Keating Financial Advisory Services’s Portfolio ANVS Stock Details ANVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.41K	Buy	+1,082	New	+$2.97K	﹤0.01%	1768

Other funds holding ANVS

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

MFG

Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

Keating Financial Advisory Services's ANVS Position: Q1 2026 in Review

Keating Financial Advisory Services opened a new position in Annovis Bio (ANVS) in Q1 2026: 1,082 shares worth $2.41K. The stake represents ﹤0.01% of the portfolio and ranks #1768 among its holdings.

56 funds tracked by Wall St. Rank hold ANVS as of Q1 2026.

Keating Financial Advisory Services held 1,082 shares of Annovis Bio worth $2.41K as of Q1 2026.
Annovis Bio was a new Keating Financial Advisory Services position in Q1 2026.
Annovis Bio made up ﹤0.01% of Keating Financial Advisory Services's portfolio in Q1 2026, its #1768 holding.
56 funds tracked by Wall St. Rank held Annovis Bio as of Q1 2026.

Based on Keating Financial Advisory Services's 13F filing for Q1 2026, filed 15 May 2026.